Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

I.R.H.M. Konings; M.J.A. de Jonge; H. Burger; A. van der Gaast; L.E.C. van Beijsterveldt; H. Winkler; J. Verweij; Z. Yuan; P. Hellemans; F.A.L.M. Eskens

doi:10.1038/sj.bjc.6605867

Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

I.R.H.M. Konings
, M.J.A. de Jonge
, H. Burger
, A. van der Gaast
, L.E.C. van Beijsterveldt
, H. Winkler
, J. Verweij
, Z. Yuan
, P. Hellemans
, F.A.L.M. Eskens

Research output: Contribution to journal › Article › Academic › peer-review

24 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	987-992
Journal	British journal of cancer
Volume	103
Issue number	7
DOIs	https://doi.org/10.1038/sj.bjc.6605867
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/sj.bjc.6605867

256904Final published version, 442 KB

Cite this

Konings, I. R. H. M., de Jonge, M. J. A., Burger, H., van der Gaast, A., van Beijsterveldt, L. E. C., Winkler, H., Verweij, J., Yuan, Z., Hellemans, P., & Eskens, F. A. L. M. (2010). Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours. British journal of cancer, 103(7), 987-992. https://doi.org/10.1038/sj.bjc.6605867

@article{d9086c62cd06402cb8e803214e67bdbd,

title = "Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours",

author = "I.R.H.M. Konings and \{de Jonge\}, M.J.A. and H. Burger and \{van der Gaast\}, A. and \{van Beijsterveldt\}, L.E.C. and H. Winkler and J. Verweij and Z. Yuan and P. Hellemans and F.A.L.M. Eskens",

year = "2010",

doi = "10.1038/sj.bjc.6605867",

language = "Undefined/Unknown",

volume = "103",

pages = "987--992",

journal = "British journal of cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "7",

}

Konings, IRHM, de Jonge, MJA, Burger, H, van der Gaast, A, van Beijsterveldt, LEC, Winkler, H, Verweij, J, Yuan, Z, Hellemans, P & Eskens, FALM 2010, 'Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours', British journal of cancer, vol. 103, no. 7, pp. 987-992. https://doi.org/10.1038/sj.bjc.6605867

TY - JOUR

T1 - Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

AU - Konings, I.R.H.M.

AU - de Jonge, M.J.A.

AU - Burger, H.

AU - van der Gaast, A.

AU - van Beijsterveldt, L.E.C.

AU - Winkler, H.

AU - Verweij, J.

AU - Yuan, Z.

AU - Hellemans, P.

AU - Eskens, F.A.L.M.

PY - 2010

Y1 - 2010

U2 - 10.1038/sj.bjc.6605867

DO - 10.1038/sj.bjc.6605867

M3 - Article

C2 - 20823884

SN - 0007-0920

VL - 103

SP - 987

EP - 992

JO - British journal of cancer

JF - British journal of cancer

IS - 7

ER -